HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Ophthalmology5 papers

Recurrent external ophthalmoplegia

Last edited: 4/15/2026

Overview

Recurrent external ophthalmoplegia refers to repeated episodes of extraocular muscle weakness or paralysis affecting eye movement, often secondary to ocular trauma or surgery, leading to symptoms such as diplopia and restricted ocular motility. 1

Diagnosis

  • Clinical Presentation: Diplopia, restricted eye movement, and signs of ocular muscle weakness.
  • Imaging: Ophthalmic ultrasound or MRI may reveal vitreous strands or adhesions.
  • Slit-lamp Examination: Identification of vitreous strands adherent to ocular structures.
  • Visual Acuity Testing: To assess functional impact and monitor treatment efficacy. 1

    • Management

  • First-Line Treatment: Nd:YAG laser vitreolysis for disrupting vitreous strands adherent to surgical wounds.
  • Indications: Particularly effective for cases with pupillary distortions and/or cystoid macular edema.
  • Outcome: Vision improvement in approximately 50% of cases, with significant visual acuity gains noted postoperatively. 1

    • Special Populations

  • No Specific Data Provided: Abstracts do not cover management specifics for pregnancy, pediatrics, elderly, or comorbid conditions.

    • Key Recommendations

  • Consider Nd:YAG laser vitreolysis as the initial treatment for recurrent external ophthalmoplegia due to vitreous strands incarcerated in surgical wounds, showing promising visual outcomes. (Evidence: Moderate) 1
  • Regular slit-lamp examination and visual acuity testing are essential for monitoring disease progression and treatment effectiveness. (Evidence: Expert opinion) 1

    • References

    1 Levy JH, Pisacano AM. Clinical experience with Nd:YAG laser vitreolysis in the anterior segment. Journal of cataract and refractive surgery 1987. link80111-6)

    Original source

    1. [1]
      Clinical experience with Nd:YAG laser vitreolysis in the anterior segment. — Levy JH, Pisacano AM Journal of cataract and refractive surgery (1987)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG